Nova Scotia Journal

Omicron causes for 73.2 % Covid cases in the United States

Covid cases in the United States

Key Takeaways:

  • The variant of Omicron Covid In the United States, the Centers for Disease Control and Prevention reported a spike based on data from the week ending Saturday.

According to health officials, the rapidly spreading Omicron variant is now the dominant strain of Covid-19 in the United States, as the WHO called for increased efforts to ensure the pandemic ends next year.

The new variant has aided record case surges, forcing some countries to reintroduce harsh restrictions. However, in the United States, President Joe Biden does not intend to “lock down the country,” according to press secretary Jen Psaki earlier in the day.

The Centers for Disease Control or Prevention, Omicron now accounts for 73.2 percent of new cases in the US in the week ending Saturday. In some parts of the country, such as the Pacific Northwest, the South, and Midwest, it already accounts for more than 90% of new infections.

The White House reported that a mid-level, fully vaccinated, and boosted staff member had tested positive for Covid-19 three days prior after spending 30 minutes in proximity to the president. So far, Biden has tested negative.

Covid-19 testing center; Image from Hindustantimes

Despite clues that it is not more severe than the Delta variant, preliminary data suggests that Omicron may be more infectious and have higher vaccine resistance.

In November, Omicron has been determined in dozens of countries since it was first reported in South Africa, dashed hopes that the pandemic worst is over.

The European Union approved the fifth Covid-19 vaccine from the US firm Novavax on Monday, putting Europe far ahead of the repose of the world in terms of vaccine and booster shot rollout.

The vaccine’s approval, which uses a more traditional technology than other Covid vaccines, has raised hopes that people who have been nervous about getting vaccinated will now do so.

Pfizer, Moderna, AstraZeneca, and Johnson & Johnson are among the other vaccines approved in the EU. In addition, the EU has already agreed to purchase up to 200 million doses of the two-shot Novavax vaccine.

“At a time when the Omicron is rapidly spreading… I am especially pleased with today’s authorization of the Novavax vaccine,” said EU Chief Ursula von der Leyen in a statement. time

Source: NDTV News

Get Nova scotia and Canada’s top News, Latest News, and other News of the world only at the most trustable news website of Canada Novascotiajournal.com

Show More

Leave a Reply

Your email address will not be published.